Amanda E. Brinker

484 total citations
15 papers, 351 citations indexed

About

Amanda E. Brinker is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Amanda E. Brinker has authored 15 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Infectious Diseases. Recurrent topics in Amanda E. Brinker's work include Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Polyamine Metabolism and Applications (3 papers). Amanda E. Brinker is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Polyamine Metabolism and Applications (3 papers). Amanda E. Brinker collaborates with scholars based in United States, United Kingdom and Türkiye. Amanda E. Brinker's co-authors include Carolyn J. Vivian, Danny R. Welch, Devin C. Koestler, Roy A. Jensen, Wen Liu, Evi Lianidou, Priyanka Ray, Saborni Chakraborty, Snigdha Banerjee and Sushanta K. Banerjee and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Amanda E. Brinker

15 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda E. Brinker United States 11 207 77 76 43 39 15 351
Gopal Pathuri United States 12 198 1.0× 91 1.2× 74 1.0× 80 1.9× 55 1.4× 44 487
Zhengfeng Wang China 9 213 1.0× 89 1.2× 82 1.1× 41 1.0× 38 1.0× 17 392
Deep Pokharel Australia 8 277 1.3× 137 1.8× 109 1.4× 42 1.0× 44 1.1× 9 385
María José Guillén Spain 11 164 0.8× 96 1.2× 48 0.6× 82 1.9× 53 1.4× 45 385
Kathrine Damm Meyle Denmark 8 242 1.2× 135 1.8× 68 0.9× 22 0.5× 19 0.5× 10 415
Shawn M. Heidel United States 9 185 0.9× 68 0.9× 102 1.3× 51 1.2× 25 0.6× 11 428
Sung-Won Shin South Korea 14 310 1.5× 111 1.4× 103 1.4× 23 0.5× 53 1.4× 24 553
Pouria Khani Iran 7 173 0.8× 72 0.9× 94 1.2× 62 1.4× 92 2.4× 13 386
Farzad Nasri Iran 6 169 0.8× 72 0.9× 93 1.2× 64 1.5× 96 2.5× 13 388
Qie Guo China 13 209 1.0× 100 1.3× 77 1.0× 89 2.1× 60 1.5× 41 497

Countries citing papers authored by Amanda E. Brinker

Since Specialization
Citations

This map shows the geographic impact of Amanda E. Brinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda E. Brinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda E. Brinker more than expected).

Fields of papers citing papers by Amanda E. Brinker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda E. Brinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda E. Brinker. The network helps show where Amanda E. Brinker may publish in the future.

Co-authorship network of co-authors of Amanda E. Brinker

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda E. Brinker. A scholar is included among the top collaborators of Amanda E. Brinker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda E. Brinker. Amanda E. Brinker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Weir, Scott J., Prasad Dandawate, David Standing, et al.. (2021). Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. Cell Death and Disease. 12(6). 562–562. 11 indexed citations
2.
Ray, Priyanka, Inamul Haque, Omar F. Mohammed, et al.. (2021). The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine. 5(1). 19–33. 76 indexed citations
3.
Weir, Scott J., Amanda E. Brinker, Prabhu Ramamoorthy, et al.. (2019). Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs. Journal of Pharmacology and Experimental Therapeutics. 370(2). 148–159. 17 indexed citations
4.
Brinker, Amanda E., Carolyn J. Vivian, Thomas C. Beadnell, et al.. (2019). Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner. Cancer Research. 80(5). 1118–1129. 17 indexed citations
5.
Weir, Scott J., Amanda E. Brinker, Paul Toren, et al.. (2019). Pharmacokinetics of ciclopirox prodrug, a novel agent for the treatment of bladder cancer, in animals and humans.. Journal of Clinical Oncology. 37(15_suppl). e14705–e14705. 6 indexed citations
6.
Weir, Scott J., Prabhu Ramamoorthy, Michael J. McKenna, et al.. (2018). Abstract 5882: Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer. Cancer Research. 78(13_Supplement). 5882–5882. 2 indexed citations
7.
Vivian, Carolyn J., et al.. (2018). Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models. Cancer and Metastasis Reviews. 37(4). 633–642. 9 indexed citations
8.
Weir, Scott J., Prabhu Ramamoorthy, John L. Haslam, et al.. (2018). Preclinical development of ciclopirox prodrug for the treatment of non-muscle invasive and muscle invasive bladder cancer.. Journal of Clinical Oncology. 36(15_suppl). e14576–e14576. 4 indexed citations
9.
Brinker, Amanda E., et al.. (2017). Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver–Dependent Manner. Cancer Research. 77(24). 6941–6949. 30 indexed citations
10.
Vivian, Carolyn J., Amanda E. Brinker, Stefan Graw, et al.. (2017). Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression. Cancer Research. 77(22). 6202–6214. 48 indexed citations
11.
Tan, Ee Phie, Zhen Zhang, Miranda Machacek, et al.. (2016). Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects. Cell Cycle. 15(10). 1363–1375. 25 indexed citations
12.
Sampson, Kathleen E., et al.. (2014). Zinc Finger Nuclease–Mediated Gene Knockout Results in Loss of Transport Activity for P-Glycoprotein, BCRP, and MRP2 in Caco-2 Cells. Drug Metabolism and Disposition. 43(2). 199–207. 28 indexed citations
13.
Liu, Wen, et al.. (2014). Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey. Cancer Microenvironment. 7(3). 117–131. 51 indexed citations
14.
Brinker, Amanda E., et al.. (2012). Use of Zinc Finger Nuclease Technology to Knock Out Efflux Transporters in C2BBe1 Cells. Current Protocols in Toxicology. 52(1). Unit 23.2.–Unit 23.2.. 13 indexed citations
15.
Brinker, Amanda E., et al.. (2002). New insights into the clinical pharmacokinetics of trofosfamide. International Journal of Clinical Pharmacology and Therapeutics. 40(8). 376–381. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026